Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1

Journal of Virology
Keun Young Hwang, Young Bong Choi

Abstract

Mitochondrial lipid raft-like microdomains, experimentally also termed mitochondrial detergent-resistant membrane fractions (mDRM), play a role as platforms for recruiting signaling molecules involved in antiviral responses such as apoptosis and innate immunity. Viruses can modulate mitochondrial functions for their own survival and replication. However, viral regulation of the antiviral responses via mDRM remains incompletely understood. Here, we report that human herpesvirus 8 (HHV-8) gene product viral interferon regulatory factor 1 (vIRF-1) is targeted to mDRM during virus replication and negatively regulates the mitochondrial antiviral signaling protein (MAVS)-mediated antiviral responses. The N-terminal region of vIRF-1 interacts directly with membrane lipids, including cardiolipin. In addition, a GxRP motif within the N terminus of vIRF-1, conserved in the mDRM-targeting region of mitochondrial proteins, including PTEN-induced putative kinase 1 (PINK1) and MAVS, was found to be important for vIRF-1 association with mitochondria. Furthermore, MAVS, which has the potential to promote vIRF-1 targeting to mDRM possibly by inducing cardiolipin exposure on the outer membrane of mitochondria, interacts with vIRF-1, which, in tu...Continue Reading

References

Jun 26, 1999·Biochemical and Biophysical Research Communications·K OhtaK Kitajima
Mar 2, 2005·Nature Reviews. Molecular Cell Biology·H Jane Dyson, Peter E Wright
Oct 7, 2005·Human Molecular Genetics·Laura SilvestriGiorgio Casari
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Dong LiZhijian J Chen
Oct 19, 2006·Methods in Enzymology·Sviatoslav N BagriantsevSusan W Liebman
Apr 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yan YangStanley M Lemon
May 15, 2007·Trends in Endocrinology and Metabolism : TEM·Irini ManoliGeorge P Chrousos
Sep 4, 2007·Trends in Cell Biology·Duncan T BrowmanStephen M Robbins
Nov 28, 2007·Annual Review of Pathology·Don Ganem
May 20, 2008·Journal of Proteome Research·Jun ZhangPeipei Ping
Jun 3, 2008·PLoS Pathogens·Lorenzo GalluzziGuido Kroemer
Nov 11, 2008·Protein and Peptide Letters·Andrew CampenA Keith Dunker
Jan 13, 2009·Journal of Lipid Research·Yu Zi ZhengLeonard J Foster
May 1, 2009·PloS One·Yu LeiJenny P-Y Ting
Sep 1, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Hye-Ra LeeJae U Jung
Jan 16, 2010·Cell Death and Differentiation·L CiarloMaurizio Sorice
May 11, 2010·Cell·Evelyn DixitJonathan C Kagan
Jun 18, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Congwen WeiHui Zhong
Aug 12, 2010·PLoS Pathogens·Young Bong Choi, John Nicholas
Jan 7, 2011·Journal of Virology·Suresh H BasagoudanavarSiddharth Balachandran
Apr 12, 2011·Expert Opinion on Therapeutic Targets·Chen WangBo Wei
May 20, 2011·Journal of Virology·Soratree CharoenthongtrakulEdward William Harhaj
May 21, 2011·Nature Reviews. Immunology·A Phillip WestSankar Ghosh
Aug 17, 2011·Proceedings of the National Academy of Sciences of the United States of America·Stacy M HornerMichael Gale
Nov 1, 2011·Biochemical and Biophysical Research Communications·Chloe N PostonCarthene R Bazemore-Walker
Mar 20, 2012·Cell·Jodi Nunnari, Anu Suomalainen
Jan 1, 2011·Frontiers in Immunology·Sarah R Jacobs, Blossom Damania
Sep 7, 2013·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Emily Cousins, John Nicholas
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Feb 1, 2014·Nature Methods·Florian HeigwerMichael Boutros
Mar 13, 2014·Annual Review of Biochemistry·Christopher J Oldfield, A Keith Dunker
Jul 31, 2014·Nature Methods·Neville E SanjanaFeng Zhang
Dec 31, 2014·Nature Methods·Jianyi YangYang Zhang
Feb 6, 2015·Apoptosis : an International Journal on Programmed Cell Death·Tina GarofaloMaurizio Sorice

Citations

Sep 2, 2016·The Journal of Clinical Investigation·Dirk P Dittmer, Blossom Damania
Oct 21, 2016·Drug Development Research·Walter H MoosKosta Steliou
Oct 14, 2016·Molecular and Cellular Biology·Young Bong ChoiEdward William Harhaj
Oct 5, 2018·Journal of Translational Medicine·Santa RasaEuropean Network on ME/CFS (EUROMENE)
Jun 27, 2019·Viruses·Qizhi LiuPinghui Feng

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Virology & CRISPR

This feed focuses on the virology of CRISPR and its use in developing CRISPR-Cas systems. Discover the latest research here.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.